Targeting AKT and DNA-PK as a therapeutic strategy in platinum-resistant high-grade serous ovarian cancer

被引：0
|
作者：
Rinne, N. [1 ]
Curry, E. [1 ]
Fotopoulou, C. [1 ]
Gabra, H. [1 ,2 ]
Cunnea, P. [1 ]
机构：
[1] Imperial Coll London, Ovarian Canc Act Res Ctr, Dept Canc & Surg, London, England
[2] AstraZeneca, IMED Biotech Unit, Early Clin Dev, Cambridge, England
来源：
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 2019年 / 126卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
1985
引用
收藏
页码：88 / 89
页数：2
相关论文
共 50 条
  • [21] The microtubule inhibitor eribulin demonstrates efficacy in platinum-resistant and refractory high-grade serous ovarian cancer patient-derived xenograft models
    Ho, Gwo Yaw
    Vandenberg, Cassandra J.
    Lim, Ratana
    Christie, Elizabeth L.
    Garsed, Dale W.
    Lieschke, Elizabeth
    Nesic, Ksenija
    Kondrashova, Olga
    Ratnayake, Gayanie
    Radke, Marc
    Penington, Jocelyn S.
    Carmagnac, Amandine
    Heong, Valerie
    Kyran, Elizabeth L.
    Zhang, Fan
    Traficante, Nadia
    Huang, Ruby
    Dobrovic, Alexander
    Swisher, Elizabeth M.
    McNally, Orla
    Kee, Damien
    Wakefield, Matthew J.
    Papenfuss, Anthony T.
    Bowtell, David D. L.
    Barker, Holly E.
    Scott, Clare L.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [22] mTOR complex inhibition as a novel therapeutic strategy in high-grade papillary serous ovarian cancer
    Musa, Fernanda
    Alard, Amandine
    David-West, Gizelka
    Giuroiu, Iulia
    Blank, Stephanie
    Pothuri, Bhavana
    Curtin, John P.
    Schneider, Robert
    CANCER RESEARCH, 2014, 74 (19)
  • [23] Targeting estrogen metabolism in high-grade serous ovarian cancer shows promise to overcome platinum resistance
    Marolt, Nika
    Pavlic, Renata
    Kreft, Tinkara
    Gjogorska, Marija
    Rizner, Tea Lanisnik
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 177
  • [24] New approaches for targeting platinum-resistant ovarian cancer
    McMullen, Michelle
    Madariaga, Ainhoa
    Lheureux, Stephanie
    SEMINARS IN CANCER BIOLOGY, 2021, 77 : 167 - 181
  • [25] Targeting the tumour microenvironment in platinum-resistant ovarian cancer
    Cummings, M.
    Freer, C.
    Orsi, N. M.
    SEMINARS IN CANCER BIOLOGY, 2021, 77 : 3 - 28
  • [26] The Potential of Targeting Ribosome Biogenesis in High-Grade Serous Ovarian Cancer
    Yan, Shunfei
    Frank, Daniel
    Son, Jinbae
    Hannan, Katherine M.
    Hannan, Ross D.
    Chan, Keefe T.
    Pearson, Richard B.
    Sanij, Elaine
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (01):
  • [27] Modeling platinum sensitive and resistant high-grade serous ovarian cancer: development and applications of experiment alsystems
    Cunnea, Paula
    Stronach, Euan A.
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [28] Targeting the PI3K/AKT/mTOR pathway in epithelial ovarian cancer, therapeutic treatment options for platinum-resistant ovarian cancer
    Rinne, Natasha
    Christie, Elizabeth L.
    Ardasheva, Anastasia
    Kwok, Chun Hei
    Demchenko, Nikita
    Low, Caroline
    Tralau-Stewart, Catherine
    Fotopoulou, Christina
    Cunnea, Paula
    CANCER DRUG RESISTANCE, 2021, 4 (03) : 573 - 595
  • [29] AKT Isoforms Interplay in High-Grade Serous Ovarian Cancer Prognosis and Characterization
    Azzalini, Eros
    Tierno, Domenico
    Bartoletti, Michele
    Barbazza, Renzo
    Giorda, Giorgio
    Puglisi, Fabio
    Cecere, Sabrina Chiara
    Losito, Nunzia Simona
    Russo, Daniela
    Stanta, Giorgio
    Canzonieri, Vincenzo
    Bonin, Serena
    CANCERS, 2022, 14 (02)
  • [30] Chloroxine overrides DNA damage tolerance to restore platinum sensitivity in high-grade serous ovarian cancer
    Vera L. Silva
    Jayeta Saxena
    Francesco Nicolini
    Joseph I. Hoare
    Stephen Metcalf
    Sarah A. Martin
    Michelle Lockley
    Cell Death & Disease, 12
12345